✦ LIBER ✦

Remoxipride — A selective dopamine D2 antagonist in the treatment of acute schizophrenia: a Canadian multicentre clinical trial

✍ Scribed by Awad, A.G.; Lapierre, Y.D.; Nair, N.P.V.; Beaudry, P.; Saxena, B.; Chouinard, G.; MacClure, J.; Jones, B.; Bakish, D.; Ancill, R.; Max, P.; Sandor, P.; Manchanda, R.

Book ID: 122354568
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 82 KB
Volume: 3
Category: Article
ISSN: 0920-9964
DOI: 10.1016/0920-9964(90)90121-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The new selective dopamine D2 antagonist

The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial

✍ Awad, A.G.; Lapierre, Y.D.; Nair, N.P.V.; Beaudry, P.; Saxena, B.; Chouinard, G. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Selective dopamine D2 antagonist, remoxi

Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studies

✍ Awad, A.G.; Ancill, R.; Awad, A.G.; Bakish, D.; Beaudry, P.; Bloom, D.; Chouinar 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 81 KB

On the clinical profile of remoxipride—E

On the clinical profile of remoxipride—Experiences from a clinical trial programme in the acute treatment of schizophrenia

✍ Lewander, T.; Westerbergh, S.-E.; Ogenstad, S.; Blomqvist, M.; Gustafsson, B. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 101 KB

P-4-33 NNC 01-0687, a selective dopamine

P-4-33 NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia. A phase II clinical trial

✍ J. Karle; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Andersen; C. Fens 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Effects of the Dopamine D2 Selective Rec

Effects of the Dopamine D2 Selective Receptor Antagonist Remoxipride on Dopamine Turnover in the Rat Brain after Acute and Repeated Administration

✍ Magnusson, Olle ;Mohringe, Bodil ;Thorell, Gun ;Lake-Bakaar, Desmond M. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

NNC 01-0687, a selective dopamine D1 rec

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia

✍ J. Karle; H. Lublin; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Anders 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 218 KB